NEURAGEN NERVE GUIDE 6MM ID X 3CM LENGTH
Report
- Report Number
- 1121308-2016-00013
- Event Type
- Injury
- Date Received
- June 30, 2016
- Date of Event
- June 8, 2016
- Report Date
- June 10, 2016
- Manufacturer
- INTEGRA LIFESCIENCES CORPORATION
- Product Code
- JXI
- PMA / PMN Number
- K011168
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- AUDIOLOGIST
Narratives
INTEGRA HAS COMPLETED THEIR INTERNAL INVESTIGATION ON 01/20/2017. THE INVESTIGATION ACTIVITIES INCLUDED: METHODS: REVIEW OF DEVICE HISTORY RECORDS. REVIEW OF COMPLAINT HISTORY. RESULTS: THE FINISHED GOODS LOT 1141379, CATALOG PNG630 ¿ (B)(4), WAS MANUFACTURED ON 04/07/14 AND ITS EXPIRATION DATE WAS 2016-04. THE REPORTED FINISHED GOODS PRODUCT LOT ASSOCIATED WITH THIS COMPLAINT IS NEURAGEN NERVE GUIDE LOT # 1141379 (ANASCO LOT) FOR WHICH THE CORRESPONDING CMC PLAINSBORO LOT# IS 105000300232. THIS PRODUCT LOT STEMS FROM THE DISPERSION LOT 105000300231. ALL TESTING MET REQUIREMENTS, AND WERE ACCEPTABLE. ZERO COMPLAINT OF THE SAME NATURE HAVE BEEN RECEIVED FOR THE PAST YEAR (0 COMPLAINT / PRODUCT USES). THIS IS NOT STATISTICALLY ADVERSE WHEN COMPARED TO THE COMPLAINT RATE FOR THE PRIOR TIME PERIOD (0 COMPLAINT / PRODUCT USES). CONCLUSION: BASED ON THE INVESTIGATION PERFORMED BY INTEGRA, THE COMPLAINT REPORTED BY THE EUROPEAN HOSPITAL OF MARSEILLE IS NOT CONFIRMED. AS PER THE CONSIGNMENT CONTRACT SIGNED BETWEEN THE CUSTOMER AND INTEGRA, THIS IS THE RESPONSIBILITY OF THE CUSTOMER TO MANAGE EXPIRY DATES. MOREOVER, REGARDLESS OF THE CONTRACT, THIS IS THE RESPONSIBILITY OF THE HOSPITAL TO CHECK THE IMPLANT (EXPIRY DATE INCLUDED) BEFORE IMPLANTING IT INTO THE PATIENT.
IT IS REPORTED A DEVICE IN CONSIGNMENT WAS USED ON (B)(6) 2016 BUT THE DEVICE IMPLANTED HAD AN EXPIRY DATE OF 30APR2016. NO PATIENT IMPACT INFORMATION PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 417776 | NEURAGEN NERVE GUIDE 6MM ID X 3CM LENGTH | NEURAGEN | JXI | INTEGRA LIFESCIENCES CORPORATION | 1141379 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Other |